Tsukuba Repository (Tulips-R) Univ. of Tsukuba
 

つくばリポジトリ (Tulips-R) >
0 コンテンツタイプ別 (Content type) >
01 雑誌発表論文等 (Journal article, etc.) >
Journal of clinical pharmacology >

Please use this identifier to cite or link to this item: http://hdl.handle.net/2241/108158

Title: Effects of Mexiletine, a CYP1A2 Inhibitor, on Tizanidine Pharmacokinetics and Pharmacodynamics
Authors: Momo, Kenji
Homma, Masato
Osaka, Yoshiko
Inomata, Shin-ichi
Tanaka, Makoto
Kohda, Yukinao
本間, 真人
猪股, 伸一
田中, 誠
幸田, 幸直
Issue Date: Mar-2010
Publisher: Sage Publications
Journal Title: Journal of clinical pharmacology
Volume: 50
Issue: 3
Start Page: 331
End Page: 337
DOI: 10.1177/0091270009341961
PMID: 19789372
Abstract: The aim of this study was to determine whether mexiletine, a CYP1A2 inhibitor, altered the pharmacokinetics and pharmacodynamics of tizanidine. The pharmacokinetics of tizanidine were examined in an open-label study in 12 healthy participants after a single dose of tizanidine (2 mg) with and without mexiletine coadministration (50 mg, 3 times as a pretreatment for a day and 2 times on the study day). Compared with tizanidine alone, mexiletine coadministration increased the peak plasma concentration (1.8 ± 0.8 vs 5.3 ± 1.8 ng/mL), area under the curve (4.5 ± 2.2 vs 15.4 ± 6.5 ng·h/mL), and the half-life (1.3 ± 0.2 vs 1.8 ± 0.7 h) of tizanidine, respectively (P < .05). Reduction in systolic blood pressure (-10 ± 8 vs -24 ± 7 mm Hg) and diastolic blood pressure (-10 ± 7 vs -18 ± 8 mm Hg) after tizanidine administration was also significantly enhanced by coadministration of mexiletine (P < .01). Of the 15 patients treated with tizanidine and mexiletine, 4 suffered tizanidine-induced adverse effects such as drowsiness and dry mouth in the retrospective survey. Present results suggested that coadministration of mexiletine increased blood tizanidine concentrations and enhanced tizanidine pharmacodynamics in terms of reduction in blood pressure and adverse symptoms.
URI: http://hdl.handle.net/2241/108158
Rights: © American College of Clinical Pharmacology, Inc.
Text Version: author
Appears in Collections:幸田 幸直 (Kohda Yukinao)
田中 誠 (TANAKA MAKOTO)
猪股 伸一 (Inomata Shinichi)
本間 真人 (Homma Masato)
Journal of clinical pharmacology

Files in This Item:

File Description SizeFormat
JCP_50-3.pdf145.65 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

DSpace Software Copyright © 2002-2008  The DSpace Foundation - Feedback